Weil Institute leaders inducted into American Society for Clinical Investigation
The society recognizes Dr. Robert Dickson and Dr. Frederick Korley for original, creative and independent investigations in the clinical and allied sciences of medicine.
Contact:
Katelyn Murphy,
Marketing Communications Specialist, Weil Institute
mukately@med.umich.edu
ANN ARBOR, MI – Two physician-scientists from the University of Michigan Max Harry Weil Institute for Critical Care Research and Innovation have been inducted into the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies.
Dr. Robert Dickson, a deputy director of the Weil Institute, and Dr. Frederick Korley, scientific director of the institute’s Massey Traumatic Brain Injury (TBI) Grand Challenge program, were recognized in December for their work in extending our understanding of diseases and improving treatment, and for their commitment to mentoring future generations of physician-scientists.
Dr. Dickson serves as Associate Professor and Associate Division Chief of Research in Pulmonary and Critical Care Medicine, as well as Associate Professor of Microbiology & Immunology. His research focuses on the role of the microbiome in lung disease and critical illness. During his work at Weil, Dr. Dickson and fellow Institute members Dr. Hallie Prescott and Dr. Robert Hyzy led the development of the Great Lakes Clinical Center, an NIH-funded consortium of leading regional healthcare institutions dedicated to accelerating new therapies for acute respiratory distress syndrome (ARDS), pneumonia and sepsis. Dr. Dickson was nominated for induction into ASCI by Dr. Alison Morris, Professor of Medicine, Immunology, and Clinical and Translational Research, and Division Chief of Pulmonary, Allergy and Critical Care Medicine at the University of Pittsburgh, and Dr. Carolyn Calfee, Professor of Medicine at the University of California San Francisco.
“I’m beyond honored to be inducted to ASCI,” said Dickson. “I consider it a recognition not just of my own research contributions, but also the endless ways I’ve been supported by my research community here at Michigan and within the Weil Institute.”
Dr. Korley serves as Professor and Associate Chair for Research in Emergency Medicine. His area of focus is on the development of novel diagnostics and therapeutics for traumatic brain injury, and he applies this expertise in his role overseeing the Weil Institute’s Massey TBI Grand Challenge and Wolverine Den programs. Korley has led multiple federally-funded multidisciplinary research projects throughout his tenure at Weil, such as a microfluidic chip that could enable point-of-care assessment of TBI severity developed in collaboration with Dr. Mark Burns, Weil member and Professor of Chemical Engineering. Dr. Korley was nominated to the ASCI by Dr. John Carethers, Vice Chancellor for Health Sciences at the University of California San Diego, and Dr. Opeolu Adeoye, BJC HealthCare Distinguished Professor and Department Chair of Emergency Medicine at the Washington University School of Medicine in St. Louis.
“It is truly a privilege and an honor to be inducted,” said Korley. “This recognition provides me with credibility and legitimacy as I continue my work on the national level to improve the emergency care received by traumatic brain injury patients.”
Established in 1908, ASCI is one of few organizations focused on the special role of physician-scientists in research, clinical care and medical education. The nomination process is highly selective, with only 100 new members accepted each year. A nomination requires one Proposer and one Seconder, and the nominees themselves must be mid-career faculty who have accomplished meritorious original, creative, and independent investigations in the clinical or allied sciences of medicine and who enjoy unimpeachable moral standing in the medical profession.
The ASCI 2024 New Active and International Members will be officially recognized in April during the joint meeting of the ASCI, Association of American Physicians, and American Physician Scientists Association in Chicago. The 2024 class also includes U-M faculty members Dr. Joanne Kahlenberg (Internal Medicine), Dr. Carl Koschmann (Pediatrics) and Dr. Sriram Venneti, (Pathology). In total, 95 U-M faculty members have been inducted into the society since 1967.
“Very few emergency physicians have been inducted into ASCI,” said Korley. “Therefore, this is not just a recognition of my personal research achievements: it is also a recognition of the growth and maturity of emergency care research.”
“I love that Fred [Korley] and I will be inducted in the same cycle,” said Dickson. “The fact that two members of the Weil Institute leadership team were inducted this year really illustrates what an accelerator it has been for our careers and research programs.”
Further Reading
ASCI Announcement: https://beta.the-asci.org/news/annual-meeting/new-active-and-international-members-elected-for-2024/
About the Weil Institute, formerly MCIRCC
The team at the Max Harry Weil Institute for Critical Care Research and Innovation (formerly the Michigan Center for Integrative Research in Critical Care) is dedicated to pushing the leading edge of research to develop new technologies and novel therapies for the most critically ill and injured patients. Through a unique formula of innovation, integration and entrepreneurship that was first imagined by Weil, their multi-disciplinary teams of health providers, basic scientists, engineers, data scientists, commercialization coaches, donors and industry partners are taking a boundless approach to re-imagining every aspect of critical care medicine. For more information, visit weilinstitute.med.umich.edu.